Treatment ot tibroadenomatosis in 14 cats with agleoristone - changes inplood oaranneters and to ow-ud

摘要

Fourteen female cats with fibroadenomatosis were treated with agleprlstone, and the effectiveness of the treatment and its effect on selected haematologlcal and blood chemistry parameters were studied. The ats were monitored for 12 months after the end of the treatment. Complete remission of the clinical gns was achieved on average 3.9 weeks after the treatment began; the success of the treatment confirmed the clinical diagnosis of fibroadenomatosis. during the course of the treatment the cats hematological parameters returned to normal.in cats that had previoysiy been treated with long-acting medroxyprogesterone acetate treatment with agleprlstone for five weeks was recommended. Cases of fibroadenomatosis reappearing after a few months should be regarded as new disease rather than a relapse. Six cats were subsequently mated and four gave birth to one or more litters; all the pregnancies proceeded normally with no clinically evident fibroadenomatosis. The other eight cats underwent ovariohysterectomy soon after the agleprlstone treatment was completed.